OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-FKBPL antibodies

Anti-FKBPL TRUEMAB Antibody Clone OTI2D8

TrueMAB™ Antibodies - Made against Authentic Protein Antigens

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA502165
  • FKBPL mouse monoclonal antibody, clone OTI2D8 (formerly 2D8)
  • Free Sample of Positive Control: HEK293T cell transient overexpression lysate (LC411782) , 20ug Explanation
100ul $379 In Stock
CF502165
  • Carrier-free (BSA/glycerol-free) FKBPL mouse monoclonal antibody, clone OTI2D8 (formerly 2D8)
100ug $450 3-4 weeks

Buy any antibody of 100ul or more, get a free package of 3 loading control antibody samples. View Details Add to Shopping Cart

spacer
WB(1)
IHC(4)
IF(1)
FC(2)
spacer
Also for FKBPL (NM_022110)
cDNA Clone shRNA/siRNA CRISPR KO Kit Protein Antibody

OriGene Data

ImmunogenFull length human recombinant protein of human FKBPL (NP_071393) produced in HEK293T cell.
Clone NameClone OTI2D8 IsotypeIgG1
Species ReactivityHuman Concentration0.71 mg/ml
Guaranteed Application *WB, IHC, IF, FC Suggested Dilutions WB 1:500, IHC 1:150, IF 1:100, FLOW 1:100,
Predicted MW Explanation 38 kDa
BufferPBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Purification Purified from mouse ascites fluids by affinity chromatography

Reference Data

Target NameHomo sapiens FK506 binding protein like (FKBPL)
Alternative NameDIR1; NG7; WISP39
Database LinkNP_071393
Entrez Gene 63943 Human
FunctionThe protein encoded by this gene has similarity to the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The encoded protein is thought to have a potential role in the induced radioresistance. Also it appears to have some involvement in the control of the cell cycle. [provided by RefSeq, Jul 2008].
Related Pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FKBPL (RC202153, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FKBPL.
spacer
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-FKBPL mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502165)
spacer
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-FKBPL mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502165)
spacer
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-FKBPL mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502165)
spacer
Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-FKBPL mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502165)
spacer
Anti-FKBPL mouse monoclonal antibody (TA502165) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FKBPL(RC202153).
spacer
Flow cytometric Analysis of Hela cells, using anti-FKBPL antibody(TA502165),(Red), compared to a nonspecific negative control antibody,(Blue).
spacer
Flow cytometric Analysis of Jurkat cells, using anti-FKBPL antibody(TA502165),(Red), compared to a nonspecific negative control antibody,(Blue).
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title